Metraipolis › archive › dc_ec75d12186cd

CD19 expression is preserved following CD19-directed monoclonal antibody therapy with tafasitamab — Europe PMC PMID:42756809

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42756809
DOI
10.3389/fimmu.2026.1878229
License (as archived)
solo-consultazione
Archived
2026-10-16T05:09:12.741Z
SHA-256 of the archived text
f48a7e23a595847c6904d4a69badd993c7bf9dc06a334885f15787c62363971f
Stable URL of this page
https://metraipolis.com/documento/dc_ec75d12186cd

How to cite

CD19 expression is preserved following CD19-directed monoclonal antibody therapy with tafasitamab — Europe PMC PMID:42756809 — Europe PMC (en), https://europepmc.org/article/MED/42756809 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ec75d12186cd (Metraipolis archive dc_ec75d12186cd, sha256 f48a7e23a595847c6904d4a69badd993c7bf9dc06a334885f15787c62363971f)
BibTeX
@misc{dcec75d12186cd,
  title = {CD19 expression is preserved following CD19-directed monoclonal antibody therapy with tafasitamab — Europe PMC PMID:42756809},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42756809},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ec75d12186cd; sha256 f48a7e23a595847c6904d4a69badd993c7bf9dc06a334885f15787c62363971f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42756809. Agents can read the archived copy with the MCP tool read_document.